Response to Pamidronate Therapy and Pharmacogenetics in Patients with Osteogenesis Imperfecta

被引：0
|
作者：
Selveindran, Nalini M. [1 ]
Hong, Janet Y. H. [1 ]
Nawawi, Nadiah Mohd [2 ]
Murad, Nor Azian Abdul [2 ]
Jamal, Rahman [2 ]
Latiff, Zarina Abdul [3 ]
Abd Aziz, Bilkis Banu [4 ]
Zakaria, Syed Zulkifli Syed [3 ]
Zain, Fuziah Md [5 ]
Rasat, Rahmah [3 ]
机构：
[1] Putrajaya Hosp, Putrajaya, Malaysia
[2] UKM Med Mol Biol Inst UMBI, Kuala Lumpur, Malaysia
[3] Univ Kebangsaan Malaya, Med Ctr, Dept Paediat, Kuala Lumpur, Malaysia
[4] UKM Med Ctr, Dept Pediat, Kuala Lumpur, Malaysia
[5] Putrajaya Hosp, Kuala Lumpur, Malaysia
来源：
HORMONE RESEARCH IN PAEDIATRICS | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3-P056
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [21] Pamidronate use in infants with Osteogenesis Imperfecta (OI).
    Elias, ER
    Tsai, CH
    Zemel, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 579 - 579
  • [22] Modeling the benefits of pamidronate in children with osteogenesis imperfecta
    Lindsay, R
    JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (09): : 1239 - 1241
  • [23] Intravenous Pamidronate in Osteogenesis Imperfecta Type VII
    Moira S. Cheung
    Francis H. Glorieux
    Frank Rauch
    Calcified Tissue International, 2009, 84 : 203 - 209
  • [24] Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate
    Lindahl, K.
    Kindmark, A.
    Rubin, C. -J.
    Malmgren, B.
    Grigelioniene, G.
    Soderhall, S.
    Ljunggren, O.
    Astrom, E.
    BONE, 2016, 87 : 11 - 18
  • [25] Large Osteoclasts in Pediatric Osteogenesis Imperfecta Patients Receiving Intravenous Pamidronate
    Cheung, Moira S.
    Glorieux, Francis H.
    Rauch, Frank
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (04) : 669 - 674
  • [26] Intravenous Pamidronate Treatment Improves Growth in Prepubertal Osteogenesis Imperfecta Patients
    Heino, Terhi J.
    Astrom, Eva
    Laurencikas, Evaldas
    Savendahl, Lars
    Soderhall, Stefan
    HORMONE RESEARCH IN PAEDIATRICS, 2011, 75 (05): : 354 - 361
  • [27] Changes in body composition following 3 years of pamidronate therapy in osteogenesis imperfecta
    Dimitri, P.
    Crook, J.
    Bishop, N.
    BONE, 2007, 40 (06) : S39 - S40
  • [28] Pamidronate in children with osteogenesis imperfecta: Histomorphometric effects of long-term therapy
    Rauch, F
    Travers, R
    Glorieux, FH
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (02): : 511 - 516
  • [29] Pamidronate therapy in children with osteogenesis imperfecta: Effect on the bone material level.
    Weber, M
    Roschger, P
    Rauch, F
    Schoeberl, T
    Fratzl-Zelman, N
    Glorieux, FH
    Fratzl, P
    Klaushofer, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S99 - S99
  • [30] Genotype-phenotype correlations and long-term efficacy of pamidronate therapy in patients with osteogenesis imperfecta
    Choi, Yunha
    Hwang, Soojin
    Kim, Gu-Hwan
    Lee, Beom Hee
    Yoo, Han-Wook
    Choi, Jin-Ho
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2022, 27 (01) : 22 - 29
12345